<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.8-a.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//pharmaceuticalintelligence.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-15-rosetta-stone-ontology-domain-specific-training-manual-for-recursive-discovery-factories/</loc>
  <lastmod>2026-04-14T02:01:22Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 15 – Rosetta Stone Ontology &amp;#038; Domain-Specific Training Manual for Recursive Discovery Factories</news:title>
   <news:publication_date>2026-04-14T01:45:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-14-24-7-autonomous-journal-article-updating-system-ajaus-integrated-architecture-ajaus-openclaw-nemoclaw/</loc>
  <lastmod>2026-04-14T01:40:11Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 14 – 24/7 Autonomous Journal Article Updating System (AJAUS): Integrated Architecture (AJAUS + OpenClaw + NemoClaw)</news:title>
   <news:publication_date>2026-04-14T01:34:31Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-13-training-data-sets-for-15-small-language-models-list-of-articles-in-each-data-set-and-methods-for-content-augmentation-for-transitioning-sml-to-llm/</loc>
  <lastmod>2026-04-14T01:26:30Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 13: Training Data Sets for 15 SMALL Language Models: List of Articles in each Data Set and Methods for Content Augmentation for Transitioning SML to LLM</news:title>
   <news:publication_date>2026-04-14T01:26:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-12-monetization-schedules-for-the-hybrid-model-human-ai-system-1-system-2-system-3-system-4/</loc>
  <lastmod>2026-04-13T23:04:35Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 12 – Monetization Schedules for the Hybrid Model, Human &amp;#038; AI: System 1, System 2, System 3, System 4</news:title>
   <news:publication_date>2026-04-13T23:04:35Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-11-validation-models-for-execution-infrastructures/</loc>
  <lastmod>2026-04-13T22:56:53Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 11 – Validation Models for Execution Infrastructures</news:title>
   <news:publication_date>2026-04-13T22:56:53Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-10-multimodal-methods-of-execution-infrastructure-ei-for-ai-data-analyses-and-exposition-of-the-analyses-results/</loc>
  <lastmod>2026-04-13T22:50:55Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 10: Multimodal Methods of Execution Infrastructure (EI) for AI Data Analyses and Exposition of the Analyses Results</news:title>
   <news:publication_date>2026-04-13T22:50:55Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-9-scoop-it-platform-aviva-launched-three-journals-since-2013-content-selection-by-domain-knowledge-expert/</loc>
  <lastmod>2026-04-13T22:37:03Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 9: Scoop.it Platform: Aviva Launched Three Journals since 2013 - Content Selection by Domain Knowledge Expert</news:title>
   <news:publication_date>2026-04-13T22:37:03Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-8-ip-asset-class-iii-aggregate-calculations-of-views-for-e-proceedings-and-tweet-collections/</loc>
  <lastmod>2026-04-13T22:20:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 8: IP Asset Class III: Aggregate Calculations of Views for e-Proceedings and Tweet Collections</news:title>
   <news:publication_date>2026-04-13T22:20:45Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-7-royalties-data-collection-on-amazon-com-kdp/</loc>
  <lastmod>2026-04-13T21:18:09Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 7: Royalties – Data collection on Amazon.com KDP</news:title>
   <news:publication_date>2026-04-13T21:18:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-6-image-type-classification-of-items-in-the-media-gallery-of-7500-biological-images/</loc>
  <lastmod>2026-04-13T21:04:14Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 6: Image Type: Classification of Items in the Media Gallery of &amp;gt;7,500 Biological Images</news:title>
   <news:publication_date>2026-04-13T21:02:16Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-5-process-workflows-for-six-ip-asset-classes/</loc>
  <lastmod>2026-04-13T20:50:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 5: Process Workflows for Six IP Asset Classes</news:title>
   <news:publication_date>2026-04-13T20:50:39Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-4-valuation-model-for-ten-ip-asset-classes/</loc>
  <lastmod>2026-04-13T20:52:54Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 4: Valuation Model for TEN IP Asset Classes</news:title>
   <news:publication_date>2026-04-13T20:42:16Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-3-exploratory-protocols-for-multimodal-foundation-model-in-healthcare/</loc>
  <lastmod>2026-04-13T16:47:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 3: Exploratory Protocols for Multimodal Foundation Model in Healthcare</news:title>
   <news:publication_date>2026-04-13T16:47:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-2-sop-on-it-aspects-of-data-management-on-the-website/</loc>
  <lastmod>2026-04-13T16:34:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 2: SOP on IT aspects of Data management on the Website</news:title>
   <news:publication_date>2026-04-13T16:34:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-1-the-curation-methodology-of-scientific-findings/</loc>
  <lastmod>2026-04-13T16:19:08Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Part 1: The “Curation Methodology” of Scientific Findings</news:title>
   <news:publication_date>2026-04-13T16:19:08Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/composition-of-methods-com/part-15-rosetta-stone-ontology-domain-specific-training-manual-for-recursive-discovery-factories/com-part-15-rosetta-stone-ontology-project-design-document-for-ai-training-manual/</loc>
  <lastmod>2026-04-14T01:47:28Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>COM – Part 15, Rosetta Stone Ontology Project &amp;#038; Design Document and AI Training Manual (Password Protected)</news:title>
   <news:publication_date>2026-04-13T15:53:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>